Advertisement
New Zealand markets closed
  • NZX 50

    11,805.09
    -141.34 (-1.18%)
     
  • NZD/USD

    0.5964
    +0.0015 (+0.24%)
     
  • NZD/EUR

    0.5557
    +0.0017 (+0.30%)
     
  • ALL ORDS

    7,830.10
    -107.40 (-1.35%)
     
  • ASX 200

    7,569.10
    -113.90 (-1.48%)
     
  • OIL

    83.89
    +0.32 (+0.38%)
     
  • GOLD

    2,348.60
    +6.10 (+0.26%)
     
  • NASDAQ

    17,430.50
    -96.30 (-0.55%)
     
  • FTSE

    8,078.86
    +38.48 (+0.48%)
     
  • Dow Jones

    38,085.80
    -375.12 (-0.98%)
     
  • DAX

    17,917.28
    -171.42 (-0.95%)
     
  • Hang Seng

    17,615.35
    +330.81 (+1.91%)
     
  • NIKKEI 225

    38,042.79
    +414.31 (+1.10%)
     
  • NZD/JPY

    93.0780
    +0.5820 (+0.63%)
     

Investors one-year losses grow to 84% as the stock sheds US$88m this past week

Even the best investor on earth makes unsuccessful investments. But it's not unreasonable to try to avoid truly shocking capital losses. So spare a thought for the long term shareholders of Sharecare, Inc. (NASDAQ:SHCR); the share price is down a whopping 84% in the last twelve months. While some investors are willing to stomach this sort of loss, they are usually professionals who spread their bets thinly. Sharecare may have better days ahead, of course; we've only looked at a one year period. Even worse, it's down 51% in about a month, which isn't fun at all. We really feel for shareholders in this scenario. It's a good reminder of the importance of diversification, and it's worth keeping in mind there's more to life than money, anyway.

Since Sharecare has shed US$88m from its value in the past 7 days, let's see if the longer term decline has been driven by the business' economics.

Check out our latest analysis for Sharecare

Sharecare isn't currently profitable, so most analysts would look to revenue growth to get an idea of how fast the underlying business is growing. When a company doesn't make profits, we'd generally expect to see good revenue growth. That's because fast revenue growth can be easily extrapolated to forecast profits, often of considerable size.

ADVERTISEMENT

Sharecare grew its revenue by 26% over the last year. We think that is pretty nice growth. However, it seems like the market wanted more, since the share price is down 84%. It could be that the losses are too much for investors to handle without losing their nerve. We'd posit that the future looks challenging, given the disconnect between revenue growth and the share price.

You can see below how earnings and revenue have changed over time (discover the exact values by clicking on the image).

earnings-and-revenue-growth
earnings-and-revenue-growth

You can see how its balance sheet has strengthened (or weakened) over time in this free interactive graphic.

A Different Perspective

Sharecare shareholders are down 84% for the year, even worse than the market loss of 20%. That's disappointing, but it's worth keeping in mind that the market-wide selling wouldn't have helped. With the stock down 42% over the last three months, the market doesn't seem to believe that the company has solved all its problems. Given the relatively short history of this stock, we'd remain pretty wary until we see some strong business performance. It's always interesting to track share price performance over the longer term. But to understand Sharecare better, we need to consider many other factors. Even so, be aware that Sharecare is showing 3 warning signs in our investment analysis , you should know about...

Of course Sharecare may not be the best stock to buy. So you may wish to see this free collection of growth stocks.

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on US exchanges.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.